NHPC:

Sudarshan Sukhani of s2analytics.com advises to exit from NHPC around Rs 22.

Sukhani told CNBC-TV18, "Go short in National Hydroelectric Power Corporation (NHPC). We have seen how NHPC has been falling relentlessly. A small upswing is considered to be a relief rally rather than the real thing. So, this relief rally is likely to face resistance at Rs 22 which is very near the current levels. Sell this stock at this level and expect a move all the way down to Rs 20 again."

Hanung Toys:

One can use this sharp rally to exit Hanung Toys partially, says Parag Doctor, Head - Trading Strategies, Keynote Capital.

Doctor told CNBC-TV18, " Hanung Toys - I would recommend to use this sharp rally which has materialized to reduce one's holdings at least partially. If you remember the stock was trading close to Rs 100 sometime back and this is a good opportunity where one can reduce his holding. Rs 140-145 is where there is strong resistance in the stock."

Aurobindo Pharma:

Sudarshan Sukhani of s2analytics.com advises to buy Aurobindo Pharma .

Sukhani told CNBC-TV18, "The markets are choppy so we have buying as well as selling. I would suggest considering Aurobindo Pharma for buy, the stock itself has made a bullish pattern. The stocks that make bullish patterns are something that we like because they are building a base and saying okay."

MMTC:

Rajesh Agarwal, Head of Research, Eastern Financiers Limited is of the view that one can sell MMTC.

Agarwal told CNBC-TV18, "I have recommended so many times to sell MMTC . This stock even after losing 80 percent from its 52-week high is still trading at ridiculous valuations, for a company which is generating Rs 100 crore odd at a market cap of Rs 21,000 crore is beyond any imagination and is a sell at this point also.

GoodReturns.in

DISCLAIMER: GoodReturns provides you with information covering shares, futures and options based on broker's reports as stated on various media. Investors are, however, warned that they should NOT take any buy or sell decision based on these views expressed in the article. Investors should consult their own financial and share advisors before taking purchase or sale decisions. GoodReturns does not take any responsibility for any losses incurred by investors who take their cues from the above article.